Epoch Biodesign Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
56
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$12M
- Investors
-
30
Epoch Biodesign General Information
Description
Operator of industrial biotechnology services intended to address the environmental and economic challenges posed by plastic waste. The company designs and develops enzymes by combining biology, artificial intelligence, and engineering capable of breaking down plastics into reusable chemicals, enabling industries to reduce plastic waste and enhance sustainability.
Contact Information
Website
www.epochbiodesign.comCorporate Office
- 10 Finsbury Square
- London EC2 1AJ
- England, United Kingdom
Corporate Office
- 10 Finsbury Square
- London EC2 1AJ
- England, United Kingdom
Epoch Biodesign Timeline
Epoch Biodesign Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 15. Later Stage VC | 25-Mar-2026 | $12M | Completed | Generating Revenue | ||
| 14. Accelerator/Incubator | 01-Mar-2026 | Completed | Generating Revenue | |||
| 13. Later Stage VC (Series A1) | 06-Mar-2025 | Completed | Generating Revenue | |||
| 12. Grant | 05-Mar-2025 | Completed | Generating Revenue | |||
| 11. Later Stage VC (Series A2) | 16-Dec-2024 | Completed | Generating Revenue | |||
| 10. Accelerator/Incubator | 20-Mar-2024 | Completed | Generating Revenue | |||
| 9. Seed Round | 14-Dec-2021 | Completed | Generating Revenue | |||
| 8. Grant | 01-Mar-2021 | Completed | Startup | |||
| 7. Seed Round | 30-Jan-2021 | $3.67M | $3.99M | Completed | Startup | |
| 6. Seed Round | 19-Jan-2021 | $321K | Completed | Startup |
Epoch Biodesign Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A1 | ||||||||
| Series A2 | ||||||||
| Seed Preferred | ||||||||
| Seed Ordinary | ||||||||
| Ordinary | 30,000 | $0.000126 | $6.29 | $6.29 | 1x | $6.29 | 1.1% | |
| Ordinary | 363,221 | $0.000126 | $8.8 | $8.8 | 1x | $8.8 | 13.37% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Epoch Biodesign Comparisons
Industry
Financing
Details
Epoch Biodesign Competitors (2)
One of Epoch Biodesign’s 2 competitors is Shiru, a Venture Capital-Backed company based in Berkeley, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Shiru | Venture Capital-Backed | Berkeley, CA | ||||
| SYMATESE | Formerly PE-Backed | Chaponost, France |
Epoch Biodesign Patents
Epoch Biodesign Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202505703-D0 | Recycling processes | Pending | 16-Apr-2025 | ||
| GB-202418775-D0 | Processes and enzymes for use therein | Pending | 19-Dec-2024 | ||
| WO-2026132812-A1 | Processes and enzymes for use therein | Pending | 19-Dec-2024 | ||
| GB-202402694-D0 | Recycling processes | Inactive | 26-Feb-2024 | ||
| GB-202314258-D0 | Recycling methods and products | Inactive | 18-Sep-2023 |
Epoch Biodesign Signals
Epoch Biodesign Investors (30)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Leitmotif | Venture Capital | Minority | ||
| Lululemon Studio | Corporation | Minority | ||
| Tech Nation Group | Accelerator/Incubator | |||
| Extantia Capital | Impact Investing | Minority | ||
| Kibo Invest | Family Office | Minority |
Epoch Biodesign Acquisitions (1)
Epoch Biodesign’s most recent deal was a Merger/Acquisition with Domo Polymer Solution Spain for . The deal was made on 11-Jun-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Domo Polymer Solution Spain | 11-Jun-2026 | Merger/Acquisition | Industrial Chemicals |
Epoch Biodesign FAQs
-
When was Epoch Biodesign founded?
Epoch Biodesign was founded in 2019.
-
Where is Epoch Biodesign headquartered?
Epoch Biodesign is headquartered in London, United Kingdom.
-
What is the size of Epoch Biodesign?
Epoch Biodesign has 56 total employees.
-
What industry is Epoch Biodesign in?
Epoch Biodesign’s primary industry is Environmental Services (B2B).
-
Is Epoch Biodesign a private or public company?
Epoch Biodesign is a Private company.
-
What is Epoch Biodesign’s current revenue?
The current revenue for Epoch Biodesign is .
-
How much funding has Epoch Biodesign raised over time?
Epoch Biodesign has raised $64.1M.
-
Who are Epoch Biodesign’s investors?
Leitmotif, Lululemon Studio, Tech Nation Group, Extantia Capital, and Kibo Invest are 5 of 30 investors who have invested in Epoch Biodesign.
-
Who are Epoch Biodesign’s competitors?
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process